Tebao Biotech announced that the company issued convertible corporate bonds “Tebao Convertible Bonds” to unspecified targets, issuing a total of 1,533 billion yuan. The original shareholders gave priority to placing 1,431 billion yuan, accounting for about 93.32% of the total distribution volume; online distribution of 102 million yuan to public investors, accounting for about 6.68%, and the online winning rate was 0.00103670%. Online investors should fulfill their capital settlement obligations on July 30, 2026 after winning the purchase of convertible bonds. The listing date of the Turbot convertible bonds issued this time will be announced separately.

Zhitongcaijing · 1d ago
Tebao Biotech announced that the company issued convertible corporate bonds “Tebao Convertible Bonds” to unspecified targets, issuing a total of 1,533 billion yuan. The original shareholders gave priority to placing 1,431 billion yuan, accounting for about 93.32% of the total distribution volume; online distribution of 102 million yuan to public investors, accounting for about 6.68%, and the online winning rate was 0.00103670%. Online investors should fulfill their capital settlement obligations on July 30, 2026 after winning the purchase of convertible bonds. The listing date of the Turbot convertible bonds issued this time will be announced separately.